Meadow Creek Wealth Advisors LLC Invests $923,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Meadow Creek Wealth Advisors LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,754 shares of the healthcare conglomerate’s stock, valued at approximately $923,000. UnitedHealth Group makes up 0.9% of Meadow Creek Wealth Advisors LLC’s investment portfolio, making the stock its 22nd largest position.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Syntegra Private Wealth Group LLC boosted its holdings in shares of UnitedHealth Group by 6.9% during the 4th quarter. Syntegra Private Wealth Group LLC now owns 2,689 shares of the healthcare conglomerate’s stock valued at $1,416,000 after purchasing an additional 173 shares during the last quarter. DeDora Capital Inc. boosted its holdings in shares of UnitedHealth Group by 2.0% during the 4th quarter. DeDora Capital Inc. now owns 9,027 shares of the healthcare conglomerate’s stock valued at $4,752,000 after purchasing an additional 174 shares during the last quarter. Brown Miller Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 0.7% in the 4th quarter. Brown Miller Wealth Management LLC now owns 5,697 shares of the healthcare conglomerate’s stock valued at $3,000,000 after acquiring an additional 42 shares during the last quarter. SeaCrest Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 12.3% in the 4th quarter. SeaCrest Wealth Management LLC now owns 3,480 shares of the healthcare conglomerate’s stock valued at $1,870,000 after acquiring an additional 380 shares during the last quarter. Finally, Ellsworth Advisors LLC lifted its holdings in shares of UnitedHealth Group by 7.8% in the 4th quarter. Ellsworth Advisors LLC now owns 931 shares of the healthcare conglomerate’s stock valued at $490,000 after acquiring an additional 67 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Up 0.3 %

UNH traded up $1.60 during trading on Thursday, hitting $494.70. The stock had a trading volume of 3,805,551 shares, compared to its average volume of 4,097,774. The company has a market capitalization of $456.08 billion, a PE ratio of 20.70, a PEG ratio of 1.34 and a beta of 0.54. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $554.70. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The stock has a 50 day simple moving average of $503.10 and a two-hundred day simple moving average of $518.61.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating the consensus estimate of $5.98 by $0.18. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. UnitedHealth Group’s revenue was up 14.1% compared to the same quarter last year. During the same period last year, the firm earned $5.34 earnings per share. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is currently 31.54%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on UNH. HSBC reissued a “reduce” rating and issued a $480.00 price objective (down previously from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Stephens reissued an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Bank of America reissued a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research note on Thursday, March 7th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 19th. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. One analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $579.33.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.